Solitary metachronous gastric metastasis from pulmonary adenocarcinoma: Report of a case  by Sileri, Pierpaolo et al.
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INTRODUCTION:  Gastric  metastases  from  lung  adenocarcinoma  are  rare  and  usually  associated  with  dis-
seminated  disease.  The  great  majority  is asymptomatic  and  in  few  cases  discovered  during  autopsy
studies.  Reports  of  single  metachronous  metastases  during  the  lifetime  are  anecdotal.  We  describe  a
case  of solitary  gastric  metastasis  5 years  after  lung  surgery.
PRESENTATION OF  CASE:  A 68-year-old  male  submitted  in  2006  to right  lobectomy  for lung  adenocar-
cinoma  was  referred  at Emergency  Room  department  in  01/2011  because  of  chronic  epigastric  pain.
Radiologic  and  endoscopic  evaluation  showed  a bulky  lesion  inside  the  stomach,  originating  from  the
muscular  layer,  suspected  for  GIST.  He  underwent  a subtotal  gastrectomy  and  the  pathologic  examination
revealed  an  undifferentiated  adenocarcinoma,  positive  for Thyroid  Transcriptional  Factor-1,  Cytokeratin
7,  AE  1/3  and  CEA,  conﬁrming  the  pulmonary  origin.
DISCUSSION: At the  time  of diagnosis  about  50%  of lung  cancer  are  metastatic,  with  survival  rates  of 1%
at  5-year.  Gastric  metastasis  is  very  rare;  autopsy  studies  report  an incidence  of 0.2–0.5%.  They  develop
in  the submucosa,  usually  without  any  symptom  and  the  diagnosis  is  incidental  during  the  staging  of
primary  cancer  or the  follow-up.  There  are  no guidelines  about  surgical  treatment;  however  few  cases
of  long-term  survival  following  the  operation  were  reported.  Pathologic  diagnosis  is difﬁcult,  but the
immunohistochemical  staining  helps  to  recognize  the  primary  origin.
CONCLUSION: Solitary  metachronous  gastric  metastasis  from  pulmonary  adenocarcinoma  is  an  excep-
tional  event,  but  it  could  happen  during  the  follow-up.  It seems  that a radical  resection,  in absence  of
 prov
ical Asystemic  implants,  might
© 2012 Surg
. Introduction
Primary lung cancers rarely metastasize to the gastrointestinal
ract. Gastric metastases are even rarer and usually associated with
isseminated disease. Generally they are not detected during the
ifetime of the patients, because most of them are asymptomatic.1
rom autopsy studies was reported an incidence as 0.2–0.5%.2,3
ctually only sporadic cases were published in the literature, par-
icularly considering metachronous metastases after several years
rom lung surgery. We  report a case of isolated metachronous
astric metastasis 5 years after surgery for pulmonary adenocar-
inoma, and review the literature on this unusual situation.∗ Corresponding author at: Department of Surgery, Policlinico Tor Vergata, Chirur-
ia  Generale UOC B, Viale Oxford 81, 00133 Rome, Italy. Tel.: +39 3285814996;
ax: +39 0620902926.
E-mail addresses: dugo.stefano@gmail.com,  stefanodugo@libero.it (S. D’Ugo).
210-2612 ©  2012 Surgical Associates Ltd. Published by Elsevier Ltd. 
ttp://dx.doi.org/10.1016/j.ijscr.2012.04.017
Open access under CCide  survival  beneﬁts  in  selected  patients.
ssociates Ltd. Published by Elsevier Ltd. 
2. Presentation of case
In January 2011, a 68-year-old Caucasian male was referred at
Emergency Room (ER) department because of chronic epigastric
pain associated with nausea and anorexia. He reported the arising of
the symptoms two months before, with weight loss of six kilograms
during this period. Up to ten years before the patient was  a smoker
of about 50 packages of cigarettes per year. The past medical history
was positive for coronary artery disease, treated with stenting in
2009, stable at the time of observation. No other comorbidities were
reported.
The cancer-related anamnesis started in 2006, when a right
upper lobectomy was performed for an undifferentiated lung
adenocarcinoma (pT3N0M0). During the 2007, a solitary lung
recurrence was diagnosed, and the patient underwent a left upper
lobectomy; the subsequent pathologic analysis conﬁrmed an undif-
ferentiated lung adenocarcinoma with features similar to the 2006
Open access under CC BY-NC-ND license.histology.
After the surgical treatment, the patient continued the regu-
lar oncological follow-up, which was  unremarkable for recurrent
 BY-NC-ND license.
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mig. 1. CT scan showing the gastric lesion involving most of the antrum (arrow).
isease until the 2011. Particularly, he was submitted to CT and
one scans every 6 months for three years and annually thereafter,
ith no evidence of disease re-activation.
At admission to ER, laboratory tests showed an increas-
ng of one the oncologic markers (CA125 = 1389.3 U/ml, n.v.
–35; CA19.9 = 19.07 U/ml; CEA = 1.55 ng/ml) and of inﬂammatory
ndexes (CRP = 96.08 mg/l; Fibrinogen = 554.8 mg/dl). Moreover a
ild anemia (Hb = 10.3 g/dl; Ht = 35.1%) and hypoalbuminemia
Albumin = 3.1 g/dl) were detected.
The patient underwent then a total body CT scan, which revealed
 lesion of the stomach, involving most of the gastric antrum,
easuring 7 cm × 5 cm;  no other abnormalities were identiﬁed
Fig. 1). Subsequently an esophagogastroduodenoscopy (EGDS) was
lanned, with report of a bulky neoplasm, protruding into the gas-
ric lumen, located in the posterior wall of the antrum. It was
overed by normal mucosa, without any sign of ulceration or ero-
ion, suggesting the presence of an extrinsic mass. Nevertheless
he following endoscopic ultrasound (EUS) deﬁned the lesion as an
val capsulated tumor, originating from the muscular layer of the
tomach, measuring more than 4 cm in maximum diameter (Fig. 2).
Based on the radiologic and endoscopic ﬁndings, suggesting a
astrointestinal stromal tumor (GIST), was planned the surgical
esection.
At laparotomy a hard mass of about 7 cm was  identiﬁed at
he level of the posterior wall of the stomach, associated to
nlarged locoregional lymph-nodes. No serosal invasion or other
ntraabdominal pathologies were evident. Consequently a subto-
al gastrectomy with a Roux-en-Y reconstruction was performed.
he postoperative course was uneventful and the patient was dis-
harged on post-operative day (POD) 9 on normal diet.
Pathological examination of the surgical specimen revealed an
ndifferentiated adenocarcinoma, as shown in Fig. 3A and B. To
ettle if the tumor was a primary gastric cancer or a metastasis
ig. 2. EGDS and EUS identifying a bulky oval capsulated neoplasm (arrows), located in t
uscular layer of the stomach, with a maximum diameter of more than 4 cm,  and was coPEN  ACCESS
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from  the lung malignancy, the analysis was integrated with the
immunohistochemical staining. The diagnosis of gastric metastasis
from lung cancer was conﬁrmed by positive staining for Thyroid
Transcriptional Factor-1 (TTF-1), Cytokeratin AE 1/3, CEA and by
the analysis of the pattern Cytokeratin 7 (CK7) positive/Cytokeratin
20 (CK20) negative (Fig. 3C and D).
After the pathologic result, the staging of the disease was  com-
pleted with a ﬂuoro-deoxy-glucose positron emission tomography
(FDG-PET)/CT scan, conﬁrming the single gastric metastasis.
Subsequently to the lung and gastric surgery an adjuvant
chemotherapy with cisplatin and vinorebine was  offered, but the
patient ﬁrmly did not consent and standard surveillance was hence
started. At the time of writing, he is regularly continuing the follow-
up at our center, without evidence of recurrence.
3. Discussion
Lung cancer accounted for approximately 27% of all new cancer
cases of both men  and women, and represented the leading cause
of cancer death world-wide. At the time of diagnosis about 50% of
the patients have metastatic disease, with reported survival rates
to be 20% at 1-year and 1% at 5-year from diagnosis.4,5 The most
common sites of extrapulmonary spread include regional lymph
nodes (72–84%), liver (33–47%), bones (21–34%), brain (16–32%),
adrenals (20–29%), and heart (12–29%).6,7
Gastrointestinal (GI) metastases from primary lung carcinoma
rarely occur.1,3 In most cases, the diagnosis is possible only at
autopsy; some necropsy studies report their incidence to be as
high as 14% and usually as part of disseminated disease.8 The few
clinical papers available indicate the incidence of symptomatic GI
metastases to be about 2%, with the most common histotype being
either squamous cells or adenocarcinoma. The small bowel is usu-
ally the most common metastatic site, while the duodenum and the
stomach are the most rare.8,9
The pathogenesis is thought to be related to the tumor cell
spread via the haematogenous and lymphatic routes, but there
is not any speciﬁc data demonstrating a particular tropism for a
segment of the GI tract.4
Symptoms and complications are secondary to a partial or
complete invasion of the intestinal wall by the neoplasm. The
most common consequences are bleeding or perforation; how-
ever, the latter was  reported also due to the tumor necrosis during
chemotherapy.10,11
Gastric metastases are very rare and in most cases asymp-
tomatic. Autopsy reports show an incidence as 0.2–0.5%,2,3 but
the actual value is difﬁcult to assess. Symptomatic localizations
to the stomach in living patients were described sporadically, as
part of disseminated disease, or as synchronous lesions at the time
of lung cancer diagnosis.12,13 The ﬁnding of a single metacronous
he posterior wall of the antrum, protruding into the lumen. It originated from the
vered by normal mucosa.
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Rig. 3. Pathological examination orienting toward an epithelial origin of the neoplas
oxylin and eosin stain, 10×; (C) CK20 immunohistochemistry stain, clone name: SP3
tain, clone name: SP52, Ventana Medical System (VMS), Tucson, AZ, USA, 20×.
etastasis, several years after the primary lung surgery as in our
ase, is exceptionally rare and incidental.
Metastases to the stomach usually develop in the submucosa,
ithout any symptom; only after a considerable growth, with the
nvolvement of other gastric layers, they could come up. Abdomi-
al pain was reported to be the most frequent symptom, generally
ssociated to chronic bleeding with haematemesis or melena,
naemia, nausea and vomiting.1 Moreover, gastric perforation and
yloric obstruction were described.2,14–17 The diagnosis is usually
ncidental during the staging procedures of primary lung cancer
r during the follow-up, as part of concomitant distal recurrences.
ET scan is the most common investigative and effective tool in
etecting GI metastases, both symptomatic or not. However, if any
ymptom appears, upper GI endoscopy usually reveals the lesion
s submucosal plaque, with or without mucosal ulceration.
In  the present case, the symptoms were secondary to the
rowth of this bulky lesion at the antro-pyloric region, leading to
pigastralgia and subtotal lumen obstruction, with consequently
ifﬁcult feeding and weight loss. As the patient was referred at
R department, the ﬁrst instrumental exam was  the total body
T scan, which ﬁrst revealed the gastric pathology. At the EGDS
he gastric mucosa appeared normal, without erosions or ulcers;
he EUS conﬁrmed the presence of one single lesion developing
able 1
eported cases of gastric metastases from primary lung carcinoma.
Author Age (yr)/gender Symptom/sign Loca
Okazaki, 201012 68/male Epigastric pain Upp
Lee, 201021 77/male Asymptomatic Mid
Ozdilekcan, 201022 46/male Disphagia, epigastric pain Less
Kanthan,  200923 75/male Epigastric-right upper quadrant pain Not
Aokage,  200819 69/male Severe anemia, fatigue Ante
Aokage,  200819 62/male Asymptomatic Post
Yang, 20064 71/male Black colored stools Not
Suzaki,  200211 45/male Epigastralgia, gastric perforation Grea
Hamatake,  200124 65/male Hematemesis Posth speciﬁc characteristics of the lung. (A) Hematoxylin and eosin stain, 2×; (B) hema-
tana Medical System (VMS), Tucson, AZ, USA, 20×; (D) CK7 immunohistochemistry
at  the submucosal/muscular interface, ruling out an extrinsic
mass.
According to the radiographic ﬁndings, Menuck et al. described
three distinct patterns of metastatic involvement of the stomach:
(1) solitary polypoid submucosal mass, which may ulcerate; (2)
multiple polypoid submucosal masses, which may  ulcerate; (3)
inﬁltrating constricting pattern similar to linitis plastica.15
In the literature was  reported a high percentage of gastric metas-
tases localized at the level of the cardias or fundus2; our case,
instead, is included in the rarer group of lesions involving the distal
portion of the organ.
From  a pathologic point of view, usually is difﬁcult to diagnose
a metastasis from a primary lung cancer to the stomach when the
histology is adenocarcinoma. However the integration with the
immunohistochemical staining allows the recognition of the pri-
mary site, even in presence of an undifferentiated cancer. In our
case the positivity of CEA and Cytokeratin AE 1/3 suggested the
epithelial origin of the neoplasia; moreover the TTF-1 is positive
in the great majority of lung adenocarcinomas, as in the present
report, but negative in gastric adenocarcinomas. Eventually we
reached the conﬁrmation analyzing the CK7+/CK20− pattern; this
is typical for lung in 90–100% of patients, conversely it is recognized
only in 35–40% of gastric cancers.
tion Timing Endoscopic features
er third and body Synchronous Linitis plastica-like tumor
-antrum Synchronous Oval-shaped ulcer with raised
margin
er curvature of gastric body Synchronous Giant gastric ulcer
 reported Synchronous Gastric polyps
rior wall of mid-stomach Metachronous Mass with central depression
(volcano-like)
erior wall of the fornix Synchronous Submucosal gastric mass (CT
scan)
 reported Synchronous Not reported
ter curvature Metachronous Not reported
erior wall of mid-stomach Synchronous Gastric ulcer
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Most extrathoracic recurrences after complete lung adenocarci-
oma resection are multiple and disseminated, associated to a poor
rognosis. Literature data on surgical treatment of single metas-
ases is scant, and no deﬁnitive conclusions can be drawn from
he small number of case reports. However some investigators
howed long-term survival after operative treatments in selected
atients; Hishida et al. reported a satisfactory outcome after resec-
ion of lung cancer recurrence in stage I patients.18 Aokage et al.
bserved prolonged survival after surgery in two  patients with
iagnosis of solitary gastric metastasis from pulmonary pleomor-
hic carcinoma.19 Moreover surgical treatment of such recurrences
ay be indicated if bleeding or obstruction is encountered.20
Table 1 shows a review of reported cases of gastric metastases
rom primary lung carcinoma, with time interval and characteris-
ics of the cancer.
.  Conclusion
Solitary metachronous gastric metastasis from pulmonary ade-
ocarcinoma several years after the primary treatment is an
xceptional event. However during the follow up it is necessary
o be aware of this rare situation. In presence of a single gastric
ocalization, after ruled out any other systemic implants, surgical
pproach is justiﬁed, with the potentiality to signiﬁcantly prolong
he disease-free survival. To have the deﬁnitive diagnosis of a pul-
onary origin is important to identify the expression of speciﬁc
mmunohistochemical patterns.
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